language_icon
EN
HI

Akums Drugs & Pharmaceuticals Share price

AKUMS

547.3

3.60 (0.66%)
NSE
BSE
Last updated on 30 Apr, 2026 | 15:49 IST
Today's High

549.95

Today's Low

536.65

52 Week Low

409.30

52 Week High

622.95

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Akums Drugs & Pharmaceuticals Chart

Akums Drugs & Pharmaceuticals Share Key Metrics

Volume
2.52 L
Market Cap
8614.17 CR
LTQ@LTP
5@547.30
ATP
543.34
Var Margin
17.47 %
Circuit Range
489.35-598.05
Delivery %
61.94 %
Value
13.67 CR
ASM/GSM
No
Market Lot
1

Summary

Akums Drugs & Pharmaceuticals share price stands at ₹547.3 at 30 Apr, 2026 | 15:49. The stock Akums Drugs & Pharmaceuticals intraday movement has stayed between ₹536.65 and ₹549.95, while on a 52-week basis it has fluctuated from ₹409.30 to ₹622.95.
In terms of trading activity, Akums Drugs & Pharmaceuticals has recorded a volume of 251599 shares. The Akums Drugs & Pharmaceuticals has a market cap of ₹157393988. The stock’s Average Traded Price (ATP) stands at ₹54334, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5, 54730.
The Akums Drugs & Pharmaceuticals operates within a circuit range of ₹489.35-598.05 – ₹489.35-598.05, with a Value of ₹13.67 CR. The Delivery Percentage for the day is 61.94%. Additionally, Akums Drugs & Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

Akums Drugs & Pharmaceuticals Fundamentals

View More
P/E Ratio

26.87

P/B Ratio

2.66

Div. Yield

0

Sector P/E

64.93

Sector P/B

3.52

Sec. Div. Yield

0.57

Akums Drugs & Pharmaceuticals Resistance and Support

Pivot 540.52

Resistance

First Resistance

553.19

Second Resistance

562.67

Third Resistance

575.34

Support

First Support

531.04

Second Support

518.37

Third Support

508.89

Akums Drugs & Pharmaceuticals Shareholding Pattern

View More
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

75.26%

Mutual Fund

10.95%

Insurance

0.6%

Foreign Institutional Investors

1.38%

Domestic Institutional Investors

2.79%

Retail

9.02%

Others

0%

Total Promoters
MAR '26
75.26%

Akums Drugs & Pharmaceuticals Corporate Actions

DateAgenda
2026-02-13Quarterly Results
2025-11-13Quarterly Results
2025-08-08Quarterly Results
2025-05-26Audited Results
2025-02-06Quarterly Results

Akums Drugs & Pharmaceuticals News

Akums Drugs and Pharmaceuticals Ltd - 544222 - Execution Of Lease Deed

Akums Drugs' wholly-owned subsidiary, Pure and Cure Healthcare, acquired an industrial plot of approximately 4050 Sq. Mtrs in Haridwar, Uttarakhand. This plot is adjacent to the existing manufacturing facility and will support the subsidiary's business operations.
Apr 29 2026 17:04:00

Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Credit Rating

Akums Drugs & Pharmaceuticals Limited's long-term credit rating has been reaffirmed at [ICRA]AA (Stable) and short-term at [ICRA]A1+. Additionally, ICRA assigned an [ICRA]A1+ rating to its proposed ₹200 crore Commercial Paper Programme, reflecting the company's strong financial profile and healthy liquidity.
Apr 11 2026 17:04:00

About Akums Drugs & Pharmaceuticals

NSE : 24715  
BSE : 544222  
ISIN : INE09XN01023  

Our Company was incorporated as a public limited company under the Companies Act 1956 as ‘Akums Drugs and Pharmaceuticals Limited’ pursuant to a certificate of incorporation dated April 19 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13 2004.Major Events and Milestones:2004-Incorporation of the Company-Established first plant for oral dosage commissioned at 19 20 21 sector 6A Haridwar Uttarakhand2007-Established dedicated manufacturing site for oral liquid dosage at 22 Sector 6A Sidcul Haridwar Uttarakhand and sterile products at 2345 Sector 6B SIDCUL Haridwar Uttarakhand2009-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals2010-Dedicated a facility for hormones at 48 Sector 6A SIDCUL Haridwar Uttarakhand-Dedicated a facility for cosmetics and dermatology at 47 Sector 6A SIDCUL Haridwar Uttarakhand-Incorporated Akumentis Healthcare Limited to venture into branded formulations2011-Innovated bi-layered sustained release tablets for the first time2012-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities2013-Innovated tablet-in-tablet sustained release tablets for the first time-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities-Expanded into the African market2015-Expanded into the Asian market-Established research and development laboratory in Mumbai Maharashtra to venture into regulated market2016-Maxcure Nutravedics Limited received US-NSF certification2019-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder2021-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs-Acquisition of a facility at Kotdwar Uttarakhand by Akums Healthcare Limited2022-Plant at 19 20 21 Sector 6A SIDCUL Haridwar Uttarakhand and plant at 2 3 45 Sector 6B SIDCUL Haridwar Uttarakhand accredited European Union-Good Manufacturing Practices qualifying for exports to European markets-Acquisition of a facility in Haridwar Uttarakhand by Akums Healthcare Limited and a facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited2023-Acquisition of another facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

Read More

Akums Drugs & Pharmaceuticals Management

NamePosition
Sanjeev JainManaging Director
Sandeep JainManaging Director
View More

Akums Drugs & Pharmaceuticals FAQs

The Buying Price of Akums Drugs & Pharmaceuticals share is 547.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Akums Drugs & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Akums Drugs & Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Akums Drugs & Pharmaceuticals shares is 26.87. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Akums Drugs & Pharmaceuticals shares is 2.66. Useful to assess the stock's value relative to its book value.

To assess Akums Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.93 & 3.52 with sector averages, along with growth rates and financial metrics.

The Market Cap of Akums Drugs & Pharmaceuticals is 8614.17 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Akums Drugs & Pharmaceuticals share price is 622.95 & 409.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Akums Drugs & Pharmaceuticals belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost